Morgan Stanley Q3 Earnings Beat on Deal-Making Boom, Solid Trading

15.10.25 16:46 Uhr

Werte in diesem Artikel
Aktien

138,96 EUR 5,24 EUR 3,92%

Indizes

PKT PKT

17.955,8 PKT 127,5 PKT 0,72%

3.326,8 PKT 16,3 PKT 0,49%

6.671,1 PKT 26,8 PKT 0,40%

Morgan Stanley’s MS third-quarter 2025 earnings of $2.80 per share handily surpassed the Zacks Consensus Estimate of $2.08. Also, the bottom line soared 49% from the prior-year quarter.Shares of Morgan Stanley jumped almost 4.5% in pre-market trading as it became the latest Wall Street giant to gain from a surge in dealmaking activities during the quarter.Behind Morgan Stanley’s Q3 Headline NumbersLike its Wall Street peers, Morgan Stanley’s investment banking (IB) business gained from a frenzy of deal-making activities and IPOs. Advisory fees jumped 25% year over year as completed M&A transactions rose. Further, higher non-investment grade and investment grade issuances supported the company’s fixed income underwriting fees, which surged 39%. Moreover, equity underwriting income soared 80% “as clients actively engaged in capital-raising opportunities.” Hence, total IB fees (in the Institutional Securities division) increased 44% to $2.11 billion. We had projected it to be $1.54 billion.Similarly, MS posted a solid trading performance. Equity trading revenues climbed 35% year over year to $4.12 billion and fixed-income trading income was up 8% to $2.17 billion. Our projections for equity and fixed-income trading revenues were $3.56 billion and $2.11 billion, respectively.Further, the performance of the company’s wealth management and investment management businesses was impressive, driven by a rise in client assets and assets under management. Morgan Stanley’s net interest income (NII) increased, given the improved lending activities. On the other hand, an increase in total non-interest expenses was the undermining factor.Net income applicable to common shareholders was $4.45 billion, an increase of 47% from the year-ago quarter. Our estimate for the metric was $3.12 billion.Morgan Stanley’s Revenues Surge, Expenses UpQuarterly net revenues were $18.22 billion, surging 18% from the prior-year quarter. The top line handily beat the Zacks Consensus Estimate of $16.4 billion.NII was $2.49 billion, up 13%. We had projected NII of $2.31 billion.Total non-interest revenues of $15.73 billion jumped 19%. Our estimate for the metric was $13.56 billion.Total non-interest expenses were $12.2 billion, up 10%. Our estimate for the metric was $11.44 billion.Provision for credit losses was nil compared with $79 million in the prior-year quarter. We had projected the metric to be $85.3 million.Morgan Stanley’s Segment PerformanceInstitutional Securities: Pre-tax income was $3.18 billion, jumping 67% from the prior-year quarter. Our estimate for the same was $2.25 billion.Net revenues were $8.52 billion, up 25% year over year. The upside resulted from increased equity and fixed income trading revenues and higher IB net revenues. We had projected segment net revenues of $7.44 billion.Wealth Management: Pre-tax income totaled $2.5 billion, rising 21% year over year. Our estimate for the metric was $1.87 billion.Net revenues were $8.23 billion, up 13%, driven by higher asset management revenues, transactional revenues and NII. We had projected revenues of $7.14 billion.Total client assets were $7.05 trillion as of Sept. 30, 2025, up 18% year over year. We had projected the metric to be $6.4 trillion.Investment Management: Pre-tax income was $364 million, climbing 40% from the year-ago quarter. Our estimate for the same was $243.2 million.Net revenues were $1.65 billion, growing 13%. The improvement was attributable to a rise in asset management and related fees, and performance-based income and other revenues. We had projected revenues of $1.46 billion.As of Sept. 30, 2025, total assets under management or supervision were $1.81 trillion, up 13% year over year. Our estimate for the metric was $1.75 trillion.Morgan Stanley’s Capital Position SolidAs of Sept. 30, 2025, book value per share was $62.98, up from $58.25 in the corresponding period of 2024. The tangible book value per share was $48.64, up from $43.76 as of Sept. 30, 2024.Morgan Stanley’s Tier 1 capital ratio (advanced approach) was 17.6% compared with 16.9% in the year-ago quarter. The common equity Tier 1 capital ratio was 15.7% compared with 14.9% a year ago.Update on Morgan Stanley’s Share Buyback PlanIn the reported quarter, Morgan Stanley repurchased 7 billion shares for $1.1 billion.Our Viewpoint on Morgan StanleyThe rebound of the IB business and a solid deal-making pipeline are expected to support Morgan Stanley’s financials. Efforts to become less dependent on capital markets-driven revenues and inorganic expansion/strategic alliances will support top-line growth. However, elevated expenses due to expansion efforts and volatile trading revenues are concerns. Morgan Stanley Price, Consensus and EPS Surprise Morgan Stanley price-consensus-eps-surprise-chart | Morgan Stanley QuoteCurrently, Morgan Stanley carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Performance of Morgan Stanley’s PeersJefferies Financial Group’s JEF third-quarter fiscal 2025 (ended Aug. 31) adjusted earnings of $1.05 per share handily surpassed the Zacks Consensus Estimate of 79 cents. The bottom line compared favorably with the prior-year quarter’s earnings of 78 cents per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.JEF’s results were aided by strong performance in Investment Banking and Capital Markets and Asset Management segments. However, higher expenses remain a spoilsport.JPMorgan’s JPM third-quarter 2025 earnings were $5.07 per share. The bottom line handily surpassed the Zacks Consensus Estimate of $4.83.Better-than-expected performance of capital markets businesses, higher NII and decent loan growth supported JPM’s results. Higher adjusted expenses and a rise in provisions were the undermining factors.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report JPMorgan Chase & Co. (JPM): Free Stock Analysis Report Morgan Stanley (MS): Free Stock Analysis Report Jefferies Financial Group Inc. (JEF): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Wer­bung

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen